These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 8985038)

  • 1. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
    Allen J; Donahue B; Mehta M; Miller DC; Rorke LB; Jakacki R; Robertson P; Sposto R; Holmes E; Vezina G; Muraszko K; Puccetti D; Prados M; Chan KW
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1006-11. PubMed ID: 19356859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.
    Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: early results of a pilot study.
    Prados MD; Wara WM; Edwards MS; Cogen PH
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):431-8. PubMed ID: 8276658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
    Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfractionated craniospinal radiation in medulloblastoma.
    Marymont MH; Geohas J; Tomita T; Strauss L; Brand WN; Mittal BB
    Pediatr Neurosurg; 1996; 24(4):178-84. PubMed ID: 8873159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
    Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
    J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
    Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
    Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy.
    Chin D; Sklar C; Donahue B; Uli N; Geneiser N; Allen J; Nirenberg A; David R; Kohn B; Oberfield SE
    Cancer; 1997 Aug; 80(4):798-804. PubMed ID: 9264364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
    Gerber NU; von Hoff K; Resch A; Ottensmeier H; Kwiecien R; Faldum A; Matuschek C; Hornung D; Bremer M; Benesch M; Pietsch T; Warmuth-Metz M; Kuehl J; Rutkowski S; Kortmann RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):863-71. PubMed ID: 24969797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of medulloblastoma and ependymoma in infants: a single-institution long-term retrospective report.
    Massimino M; Gandola L; Cefalo G; Lasio G; Riva D; Fossati-Bellani F; Gianni MC; Luksch R; Tesoro-Tess JD; Lombardi F
    Childs Nerv Syst; 2000 Jan; 16(1):15-20. PubMed ID: 10672424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.